Sharon Mates insider trades: Intra-Cellular Therapies (ITCI) stock sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Sharon reports to the SEC
Open-market buys and sales
33 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Dec 5, 2024 | ITCI | ↓ Sell | 102,697 | $84.93 | $8.7M | Direct | Dec 6, 2024 (1d) |
| Aug 30, 2024 | ITCI | ↓ Sell | 70,000 | $72.70 | $5.1M | Direct | Aug 30, 2024 (0d) |
| Aug 28, 2024 | ITCI | ↓ Sell | 95,925 | $73.54 | $7.1M | Direct | Aug 28, 2024 (0d) |
| Aug 23, 2024 | ITCI | ↓ Sell | 121,073 | $75.05 | $9.1M | Direct | Aug 23, 2024 (0d) |
| Mar 11, 2024 | ITCI | ↓ Sell | 61,277 | $66.07 | $4.0M | Direct | Mar 11, 2024 (0d) |
| Feb 26, 2024 | ITCI | ↓ Sell | 22,590 | $69.79 | $1.6M | Direct | Feb 27, 2024 (1d) |
| Feb 2, 2024 | ITCI | ↓ Sell | 33,885 | $67.07 | $2.3M | Direct | Feb 5, 2024 (3d) |
| Jan 18, 2024 | ITCI | ↓ Sell | 191,362 | $66.27 | $12.7M | Direct | Jan 18, 2024 (0d) |
| Sep 19, 2023 | ITCI | ↓ Sell | 100,000 | $53.94 | $5.4M | Direct | Sep 19, 2023 (0d) |
| Mar 13, 2023 | ITCI | ↓ Sell | 62,335 | $43.76 | $2.7M | Direct | Mar 13, 2023 (0d) |
| Feb 24, 2023 | ITCI | ↓ Sell | 22,590 | $47.03 | $1.1M | Direct | Feb 27, 2023 (3d) |
| Feb 21, 2023 | ITCI | ↓ Sell | 27,848 | $46.83 | $1.3M | Direct | Feb 22, 2023 (1d) |
| Dec 13, 2022 | ITCI | ↓ Sell | 33,083 | $55.00 | $1.8M | Direct | Dec 15, 2022 (2d) |
| Feb 24, 2022 | ITCI | ↓ Sell | 22,589 | $51.98 | $1.2M | Direct | Feb 25, 2022 (1d) |
| Feb 22, 2022 | ITCI | ↓ Sell | 27,847 | $55.39 | $1.5M | Direct | Feb 23, 2022 (1d) |
| Jan 10, 2022 | ITCI | ↓ Sell | 41,896 | $40.78 | $1.7M | Direct | Jan 11, 2022 (1d) |
| Oct 18, 2021 | ITCI | ↓ Sell | 50,000 | $40.00 | $2.0M | Direct | Oct 18, 2021 (0d) |
| Feb 19, 2021 | ITCI | ↓ Sell | 27,847 | $39.23 | $1.1M | Direct | Feb 22, 2021 (3d) |
| Jan 11, 2021 | ITCI | ↓ Sell | 41,896 | $32.01 | $1.3M | Direct | Jan 12, 2021 (1d) |
| Jan 4, 2021 | ITCI | ↓ Sell | 48,341 | $31.30 | $1.5M | Direct | Jan 5, 2021 (1d) |
| Nov 10, 2020 | ITCI | ↓ Sell | 50,000 | $26.34 | $1.3M | Direct | Nov 12, 2020 (2d) |
| Nov 4, 2020 | ITCI | ↓ Sell | 50,000 | $25.00 | $1.3M | Direct | Nov 6, 2020 (2d) |
| Jan 9, 2020 | ITCI | ↓ Sell | 41,895 | $26.16 | $1.1M | Direct | Jan 10, 2020 (1d) |
| Jan 6, 2020 | ITCI | ↓ Sell | 45,598 | $30.28 | $1.4M | Direct | Jan 8, 2020 (2d) |
| Jan 2, 2020 | ITCI | ↓ Sell | 17,478 | $32.45 | $567K | Direct | Jan 3, 2020 (1d) |
| Jan 7, 2019 | ITCI | ↓ Sell | 52,202 | $11.58 | $604K | Direct | Jan 8, 2019 (1d) |
| Jan 2, 2019 | ITCI | ↓ Sell | 17,478 | $11.09 | $194K | Direct | Jan 3, 2019 (1d) |
| Jan 8, 2018 | ITCI | ↓ Sell | 6,604 | $17.48 | $115K | Direct | Jan 10, 2018 (2d) |
| Jan 5, 2018 | ITCI | ↓ Sell | 11,257 | $17.08 | $192K | Direct | Jan 5, 2018 (0d) |
| Oct 30, 2017 | ITCI | ↓ Sell | 18,750 | $15.75 | $295K | Direct | Nov 1, 2017 (2d) |
| Jan 5, 2017 | ITCI | ↓ Sell | 4,081 | $16.55 | $68K | Direct | Jan 9, 2017 (4d) |
| Dec 11, 2015 | ITCI | ↓ Sell | 51,500 | $53.87 | $2.8M | Direct | Dec 15, 2015 (4d) |
| Nov 28, 2014 | ITCI | ↓ Sell | 35,000 | $14.75 | $516K | Direct | Nov 28, 2014 (0d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
About Sharon Mates's insider trades
Sharon Mates is Chairman and CEO at Intra-Cellular Therapies (ITCI). Since Nov 28, 2014, Sharon has reported no open-market purchases and 33 sales worth $83.6M on SEC Form 4. There have been no open-market trades in the last 12 months.
Their filings also include option exercises (34 filings), grants and awards (21 filings), shares withheld for taxes (3 filings), shares returned to the company (1 filing). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every ITCI insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.